A central testing lab may have advanced instruments and a broad testing portfolio, but these factors alone do not determine whether it can support a global clinical trial. When samples are collected across multiple countries, quality risks often appear in less visible areas, such as inconsistent processing procedures, unclear sample handling requirements, unstable transportation conditions, or gaps in quality documentation.
Before selecting a laboratory partner, sponsors need to evaluate whether the lab has the systems and experience required to maintain reliable results across different trial sites. Key evaluation factors include CAP/CLIA accreditation, assay capabilities, global logistics networks, sample stability data, and audit findings. Together, these factors provide a clearer picture of whether a laboratory can support consistent and high-quality clinical trial data.
CAP and CLIA Accreditation: The First Indicator of Laboratory Quality
Accreditation is an essential starting point when evaluating central testing labs. Standards such as CAP (College of American Pathologists) and CLIA (Clinical Laboratory Improvement Amendments) demonstrate that a laboratory follows established requirements for testing accuracy, personnel qualifications, equipment management, and quality control.
For global clinical trials, accreditation provides confidence that laboratory operations are managed through structured quality systems. Sponsors should review whether the laboratory maintains documented procedures for sample receipt, analytical testing, result verification, data management, and deviation handling.
However, accreditation should not be viewed as the only measurement of laboratory capability. A qualified laboratory should also demonstrate how these standards are implemented in daily operations. Training programs, internal quality assessments, and corrective action processes can reveal whether the laboratory has built a sustainable quality culture.
Assay Menu and Validation Experience Define Technical Capability
A laboratory’s assay menu reflects its ability to support different clinical research requirements. Global trials may involve routine safety testing, biomarker analysis, immunological assessments, pharmacokinetic studies, or specialized assays depending on the therapeutic area and development stage.
When assessing laboratory capability, sponsors should look beyond the number of available assays. Important questions include whether the laboratory has experience with similar studies, how assays are validated, what analytical performance data is available, and whether testing methods are suitable for the trial objectives.
A strong assay portfolio can reduce operational complexity by allowing multiple testing requirements to be managed within one centralized system. More importantly, experience with complex assays helps ensure that results remain consistent throughout the study rather than introducing variability caused by different testing environments.
Global Logistics Network Ensures Sample Integrity
In multinational clinical trials, laboratory performance depends not only on testing accuracy but also on how effectively samples are managed before analysis. Samples may travel across regions with different transportation conditions, customs requirements, and delivery timelines.
A reliable central testing lab should have a global logistics network that supports sample collection, shipment coordination, tracking, storage, and temperature control. These systems help prevent delays or improper handling that could affect sample quality.
During evaluation, sponsors should review how the laboratory manages the entire sample journey. This includes shipment monitoring processes, contingency plans for transportation issues, and communication systems between clinical sites and laboratory teams.
A well-designed logistics framework reduces uncertainty and helps ensure that samples collected from different locations arrive under comparable conditions, supporting more reliable laboratory results.
Sample Stability Data Supports Confidence in Results
Sample stability is another important factor when evaluating a laboratory’s technical reliability. Biological samples can be affected by storage duration, temperature changes, and transportation conditions. Without appropriate stability evaluation, sample degradation may create uncertainty in the final data.
Experienced central clinical laboratories establish stability data to demonstrate how samples perform under defined handling conditions. These studies help determine acceptable storage requirements, transportation timelines, and processing procedures.
Sponsors should review whether stability data is available for the specific sample types and assays required in their trials. This information provides evidence that laboratory workflows are supported by scientific validation and that testing results can remain dependable throughout the sample management process.
What Audit Findings Reveal About Central Laboratory Performance
Audit records provide practical insight into how a laboratory manages quality risks. A laboratory’s performance should not only be judged by whether findings exist but also by how effectively issues are identified, investigated, and resolved.
Sponsors should examine audit observations, root cause analysis reports, and corrective and preventive actions (CAPA). Repeated findings in the same area may indicate underlying process weaknesses, while effective corrective actions demonstrate a laboratory’s ability to improve.
Transparent audit management reflects operational maturity. A laboratory that actively reviews problems and strengthens its procedures is more likely to maintain consistent performance during complex global clinical trials.
Selecting a Central Testing Lab for Global Clinical Trials
Evaluating a central testing lab requires more than reviewing service lists or technical equipment. Accreditation demonstrates regulatory readiness, assay capabilities show scientific expertise, logistics networks protect sample integrity, stability data supports testing reliability, and audit findings reveal the effectiveness of quality management systems.
Tigermed provides integrated clinical development capabilities, including central laboratory services designed to support global clinical trials. Through standardized laboratory workflows, coordinated sample management, and quality-focused operations, Tigermed helps clinical teams manage complex laboratory requirements across multi-site studies.
A careful evaluation process allows sponsors to identify laboratory partners that can support consistent testing and dependable data throughout the clinical trial lifecycle. By examining measurable capabilities before study initiation, organizations can reduce operational risks and build a stronger foundation for reliable clinical research outcomes.
